BridgeBio Pharma (BBIO) Non-Current Debt (2018 - 2026)

BridgeBio Pharma (BBIO) posted Non-Current Debt of $2.7 billion for Q1 2026, up 258.07% sequentially from $740.9 million in Q4 2025.

BridgeBio Pharma (BBIO) Non-Current Debt (2018 - 2026) Analysis & Trends

BridgeBio Pharma has reported Non-Current Debt for 9 years, with the latest figure at $2.7 billion in Q1 2026.

Quarterly Non-Current Debt changed N/A year-over-year to $2.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.7 billion (changed N/A YoY) and the FY2025 annual result came in at $740.9 million, up 69.41% from the prior year.
Non-Current Debt advanced to $2.7 billion in Q1 2026 per BBIO's latest filing, from $740.9 million in the prior quarter.
Over five years, Non-Current Debt peaked at $2.7 billion in Q1 2026 and troughed at $418.4 million in Q2 2022.
A 5-year average of $707.7 million and a median of $436.2 million in 2024 frame the typical range for Non-Current Debt.
The sharpest annual moves came in 2022 and 2024: Non-Current Debt jumped 378.3% in 2022, then fell 2.04% in 2024.
Over 5 years, Non-Current Debt stood at $431.0 million in 2022, then climbed by 3.59% to $446.4 million in 2023, then dropped by 2.04% to $437.3 million in 2024, then surged by 69.41% to $740.9 million in 2025, then soared by 258.07% to $2.7 billion in 2026.
According to Business Quant data, Non-Current Debt over the past three periods registered $2.7 billion, $740.9 million, and $2.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	1.99 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	-
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	-
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	882.16 Mn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	-
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	8.96 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	-
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	546.77 Mn
10	BridgeBio Pharma	15.60 Bn	14.89 Bn	228.63 Mn	2.65 Bn

Download Data